Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#21
REVIEW
Saad Ashraf, Abbas Kamil Sh Khalaf, Laveeza Fatima, Hashim Talib Hashim, Hamza Irfan, Haider Ashfaq, Maryam Ahmed Khan, Arhamah Zahid, Umar Akram, Aman Goyal
BACKGROUND: Acute decompensated heart failure (ADHF) presents a significant global health challenge, with high morbidity, mortality, and healthcare costs. The current therapeutic options for ADHF are limited. Ivabradine, a selective inhibitor of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, has emerged as a potential therapy for ADHF by reducing the heart rate (HR) without negatively affecting myocardial contractility. However, the evidence regarding the efficacy and safety of ivabradine in patients with ADHF is limited and inconsistent...
May 8, 2024: Current Problems in Cardiology
#22
JOURNAL ARTICLE
Darby Dwyer, Shyam S Ramachandran, Kyle McCall, Masen Ragsdale, David Ring, Sina Ramtin
OBJECTIVE: We selected statements in the Official Disability Guidelines (ODG) that had the potential to reinforce misconceptions regarding symptoms from rotator cuff tendinopathy (RCT). These statements were revised and presented with the original statement to specialists. METHODS: Twelve statements regarding RCT were identified as deviating from principles based on ethics, values, and the evidence regarding both pathophysiology and human illness behavior. One hundred fifteen upper extremity surgeons reviewed both original and revised versions of the statements and indicated their preference...
May 10, 2024: Journal of Occupational and Environmental Medicine
#23
JOURNAL ARTICLE
Julie Ording, Marianne Cloeren, Brian Chen, David Caretto
Workers' compensation outpatient care requires attention to causation, functional assessment, work disability prevention and return-to-work planning, elements not usually addressed in other types of outpatient encounters. Because these elements of care deviate from the usual pattern of ambulatory services, providers of workers' compensation care have faced challenges in billing and auditing practices resulting in underpayment when providing high-value care based on evidence-based guidelines. Recent changes in Centers for Medicare and Medicaid Services rules on documentation requirements for coding outpatient evaluation and management encounters offer an opportunity for occupational health clinicians to be paid appropriately for care that follows occupational medicine practice guidelines...
May 10, 2024: Journal of Occupational and Environmental Medicine
#24
JOURNAL ARTICLE
Fredrik Granviken, Ottar Vasseljen, Kerstin Bach, Amar Jaiswal, Ingebrigt Meisingset
BACKGROUND: Common interventions for musculoskeletal pain disorders either lack evidence to support their use or have small to modest or short-term effects. Given the heterogeneity of patients with musculoskeletal pain disorders, treatment guidelines and systematic reviews have limited transferability to clinical practice. A problem-solving method in artificial intelligence, case-based reasoning (CBR), where new problems are solved based on experiences from past similar problems, might offer guidance in such situations...
May 10, 2024: JMIR Formative Research
#25
JOURNAL ARTICLE
Stella T Chou, Jeanne E Hendrickson
Transfusion of red blood cells (RBCs) can be lifesaving for individuals living with sickle cell disease (SCD). However, alloimmunization following transfusion is more common with SCD than other patient populations, resulting in morbidity and mortality. Management of complications related to RBC alloantibodies, including delayed hemolytic transfusion reactions (DHTRs) and identifying compatible RBCs for future transfusions, remains a challenge for hematologists and transfusion medicine providers. Although transfusion guidelines from organizations including the American Society for Hematology provide general recommendations, individual cases remain challenging...
May 10, 2024: Blood
#26
JOURNAL ARTICLE
Alessandro Carrera, Emanuele Lettieri, Gaia Lietti, Sara Martignoni, Chiara Sgarbossa, Joseph Cafazzo
National healthcare systems face multiple challenges, including the increasing demand for care and decreasing availability of healthcare professionals. Digital health technologies represent opportunities that offer improved efficiency, accessibility, and patient care. In this scenario, Digital Therapeutics are technological advancements to treat or alleviate a disease and deliver a medical intervention with evidence-based therapeutic impacts and regulatory approval. Digital Therapeutics are a paradigm shift for physicians, who exercise caution in terms of trust and wide usage...
2024: PloS One
#27
JOURNAL ARTICLE
Mary Lou Affronti, Jiyeon Lee, Alex Molassiotis, Lindsay Johnson, Stacey Tinianov, Rebecca Clark-Snow, Florian Scotte
PURPOSE: The Multinational Association of Supportive Care in Cancer (MASCC)/European Society of Medical Oncology (ESMO) Patient Antiemetic Guideline Committee aimed to (1) adapt the updated evidence-based, clinical guidelines to patient-centered antiemetic guidelines and (2) develop patient education materials and statements. METHODS: The MASCC 2023 Patient Antiemetic Guidelines were created and reviewed by antiemetic experts and patient advocates by incorporating the 2023 MASCC/ESMO antiemetic guidelines into patient-friendly language...
May 10, 2024: Supportive Care in Cancer
#28
REVIEW
Milton Packer, Stefan D Anker, Javed Butler, John G F Cleland, Paul R Kalra, Robert J Mentz, Piotr Ponikowski, Khawaja M Talha
According to current guidelines, iron deficiency is defined by a serum ferritin level <100 ng/ml or a transferrin saturation (TSAT) <20% if the serum ferritin level is 100-299 μg/L. These criteria were developed to encourage the use of intravenous iron as an adjunct to erythropoiesis-stimulating agents in the treatment of renal anaemia. However, in patients with heart failure, these criteria are not supported by any pathophysiological or clinical evidence that they identify an absolute or functional iron deficiency state...
May 10, 2024: European Journal of Heart Failure
#29
JOURNAL ARTICLE
Giuseppe Argenziano, Francesco Cusano, Monica Corazza, Salvatore Amato, Paolo Amerio, Luigi Naldi, Cataldo Patruno, Paolo D Pigatto, Pietro Quaglino, Paolo Gisondi, Andrea Chiricozzi, Francesco Tonon, Luca Stingeni, Piergiacomo Calzavara-Pinton, Andreas Wollenberg, Maria Kinberger, Bernd W Arents, Nora Aszodi, Gabriela L Avila Valle, Sebastien Barbarot, Thomas Bieber, Helen A Brough, Piergiacomo Calzavara-Pinton, Stéphanie Christen-Zäch, Mette Deleuran, Martin Dittmann, Corinna Dressler, Antjie H Fink-Wagner, Nicole Fosse, Krisztián Gáspár, Louise A Gerbens, Uwe Gieler, Giampiero Girolomoni, Stamatios Gregoriou, Charlotte G Mortz, Alexander Nast, Uffe Nygaard, Magali Redding, Eva M Rehbinder, Johannes Ring, Mariateresa Rossi, Esther Serra-Baldrich, Dagmar Simon, Zsuzsanna Z Szalai, Jacek C Szepietowski, Antonio Torrelo, Thomas Werfel, Carsten Flohr
The evidence- and consensus-based guideline on atopic eczema, published in JEADV on 18 August 2022 (part 1) and 3 September 2022 (part 2) was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. Twenty-nine experts (including clinicians and patient representatives) from 12 European countries participated. To reflect the most recent evidence on novel systemic medications, an update was published in October 2022...
May 10, 2024: Italian journal of dermatology and venereology
#30
JOURNAL ARTICLE
Giuseppe Argenziano, Francesco Cusano, Monica Corazza, Salvatore Amato, Paolo Amerio, Luigi Naldi, Cataldo Patruno, Paolo D Pigatto, Pietro Quaglino, Paolo Gisondi, Andrea Chiricozzi, Francesco Tonon, Luca Stingeni, Piergiacomo Calzavara-Pinton, Andreas Wollenberg, Maria Kinberger, Bernd W Arents, Nora Aszodi, Gabriela L Avila Valle, Sebastien Barbarot, Thomas Bieber, Helen A Brough, Piergiacomo Calzavara-Pinton, Stéphanie Christen-Zäch, Mette Deleuran, Martin Dittmann, Corinna Dressler, Antjie H Fink-Wagner, Nicole Fosse, Krisztián Gáspár, Louise A Gerbens, Uwe Gieler, Giampiero Girolomoni, Stamatios Gregoriou, Charlotte G Mortz, Alexander Nast, Uffe Nygaard, Magali Redding, Eva M Rehbinder, Johannes Ring, Mariateresa Rossi, Esther Serra-Baldrich, Dagmar Simon, Zsuzsanna Z Szalai, Jacek C Szepietowski, Antonio Torrelo, Thomas Werfel, Carsten Flohr
SIDeMaST (Società Italiana di Dermatologia Medica, Chirurgica, Estetica e delle Malattie Sessualmente Trasmesse) contributed to the development of the present guideline on the systemic treatment of chronic plaque psoriasis. With the permission of EuroGuiDerm, SIDeMaST adapted the guideline to the Italian healthcare context to supply a reliable and affordable tool to Italian physicians who take care of patients affected by atopic dermatitis. The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual...
May 10, 2024: Italian journal of dermatology and venereology
#31
JOURNAL ARTICLE
Giuseppe Argenziano, Francesco Cusano, Monica Corazza, Salvatore Amato, Paolo Amerio, Luigi Naldi, Cataldo Patruno, Paolo D Pigatto, Pietro Quaglino, Paolo Gisondi, Andrea Chiricozzi, Francesco Tonon, Luca Stingeni, Piergiacomo Calzavara-Pinton, Andreas Wollenberg, Maria Kinberger, Bernd W Arents, Nora Aszodi, Gabriela L Avila Valle, Sebastien Barbarot, Thomas Bieber, Helen A Brough, Piergiacomo Calzavara-Pinton, Stéphanie Christen-Zäch, Mette Deleuran, Martin Dittmann, Corinna Dressler, Antjie H Fink-Wagner, Nicole Fosse, Krisztián Gáspár, Louise A Gerbens, Uwe Gieler, Giampiero Girolomoni, Stamatios Gregoriou, Charlotte G Mortz, Alexander Nast, Uffe Nygaard, Magali Redding, Eva M Rehbinder, Johannes Ring, Mariateresa Rossi, Esther Serra-Baldrich, Dagmar Simon, Zsuzsanna Z Szalai, Jacek C Szepietowski, Antonio Torrelo, Thomas Werfel, Carsten Flohr
SIDeMaST (Società Italiana di Dermatologia Medica, Chirurgica, Estetica e delle Malattie Sessualmente Trasmesse) contributed to the development of the present guideline on the systemic treatment of chronic plaque psoriasis. With the permission of EuroGuiDerm, SIDeMaST adapted the guideline to the Italian healthcare context to supply a reliable and affordable tool to Italian physicians who take care of patients affected by atopic dermatitis. The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual...
May 10, 2024: Italian journal of dermatology and venereology
#32
REVIEW
Cristian Uceda-Portillo, Sandra Aranda-Valero, Pedro Moruno-Miralles
The increase in older adults with dementia presents challenges in promoting research to improve the quality of life of this population. The objective of this study was to assess the scientific evidence on the effectiveness of occupational therapy interventions in improving the quality of life of older adults over 65 years old with dementia living in nursing homes. The databases used were PubMed, Web of Science, OTSeeker, clinicaltrials.gov, Dialnet, Scopus, Cochrane, and SciELO between 2013 and 2023. The studies were selected and evaluated according to the Cochrane guidelines...
April 25, 2024: Healthcare (Basel, Switzerland)
#33
REVIEW
Paula Riganti, M Victoria Ruiz Yanzi, Camila Micaela Escobar Liquitay, Nadia J Sgarbossa, Christoper A Alarcon-Ruiz, Karin S Kopitowski, Juan Va Franco
BACKGROUND: In breast cancer screening programmes, women may have discussions with a healthcare provider to help them decide whether or not they wish to join the breast cancer screening programme. This process is called shared decision-making (SDM) and involves discussions and decisions based on the evidence and the person's values and preferences. SDM is becoming a recommended approach in clinical guidelines, extending beyond decision aids. However, the overall effect of SDM in women deciding to participate in breast cancer screening remains uncertain...
May 10, 2024: Cochrane Database of Systematic Reviews
#34
REVIEW
Kaituo Huang, Lingya Yao, Jing Liu, Qian Cao
In 2020, the European Medicines Agency approved subcutaneous (SC) vedolizumab (VDZ) for the maintenance treatment of adult patients with moderate to severe inflammatory bowel disease (IBD). This article reviews the efficacy, safety, persistence, pharmacology, patient satisfaction, and economic implications of transitioning to SC VDZ treatment and explores whether SC formulations can be recommended by the same guidelines as intravenous (IV) formulations. Clinical trials and real-world evidence indicate that transitioning from IV to SC VDZ in patients with IBD maintains clinical, biochemical, and patient-reported clinical remission and is well-tolerated, with no new safety issues identified, except for injection site reactions...
2024: Therapeutic Advances in Chronic Disease
#35
REVIEW
Neeraj Vij, Sailesh Tummala, Eahsan Shahriary, John Tokish, Shelden Martin
Traditional practice favors total shoulder arthroplasty (TSA) for the treatment of primary glenohumeral osteoarthritis (PGHO) with an intact rotator cuff; however, the indications for reverse shoulder arthroplasty (RSA) have expanded to include PGHO. The purpose of this systematic review is to compare the mean differences in the range of motion and patient-reported outcomes between the TSA and RSA with an intact rotator cuff and to analyze the subgroup of the Walch type B2 glenoid. This IRB-exempt, PROSPERO-registered systematic review strictly followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) guidelines...
April 2024: Curēus
#36
REVIEW
Wenting Cai, Rui Tong, Yue Sun, Yao Yao, Jinping Zhang
BACKGROUND: The European League of Rheumatology(EULAR)guidelines recommend Janus kinase (JAK) inhibitors for patients with moderate to severe rheumatoid arthritis (RA) who are insensitive or under-responsive to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs). But there was no recommendation for which one was preferred in five currently approved JAK inhibitors. The objective of this network meta-analysis study was to evaluate the efficacy of five JAK inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis...
2024: Frontiers in Pharmacology
#37
JOURNAL ARTICLE
Luke A Jelen, Rupert McShane, Allan H Young
In this editorial, we emphasise the efficacy and challenges of using ketamine in treatment-resistant depression. We highlight the need for comprehensive evidence-based guidelines to manage the use of both licensed and off-licence ketamine formulations and discuss recent efforts by Beaglehole et al to develop ketamine guidelines in New Zealand. We finally advocate for national registries to monitor ketamine therapy, ensuring its responsible and effective use in the management of depression.
May 10, 2024: BJPsych Open
#38
JOURNAL ARTICLE
Dustin D Linn, Johnathan R Renew
DISCLAIMER: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: Neuromuscular blocking agents (NMBAs) are commonly used during surgery, and restoring neuromuscular function at the end of surgery is vital in preventing complications of residual paralysis...
May 10, 2024: American Journal of Health-system Pharmacy: AJHP
#39
JOURNAL ARTICLE
Giovanni Corrao, Federico Rea, Marica Iommi, Adele Lallo, Giovanna Fantaci, Mirko Di Martino, Marina Davoli, Olivia Leoni, Marco Pompili, Salvatore Scondotto, Giovanni De Luca, Flavia Carle, Stefano Lorusso, Cristina Giordani, Andrea Di Lenarda, Aldo Pietro Maggioni
AIMS: A set of indicators to assess the quality of care for patients hospitalized for heart failure was developed by an expert working group of the Italian Health Ministry. Because a better performance profile measured using these indicators does not necessarily translate to better outcomes, a study to validate these indicators through their relationship with measurable clinical outcomes and healthcare costs supported by the Italian National Health System was carried out. METHODS AND RESULTS: Residents of four Italian regions (Lombardy, Marche, Lazio, and Sicily) who were newly hospitalized for heart failure (irrespective of stage and New York Heart Association class) during 2014-2015 entered in the cohort and followed up until 2019...
May 9, 2024: ESC Heart Failure
#40
JOURNAL ARTICLE
Edward Riley-Gibson, Alix Hall, Adam Shoesmith, Luke Wolfenden, Rachel C Shelton, Emma Doherty, Emma Pollock, Debbie Booth, Ramzi G Salloum, Celia Laur, Byron J Powell, Melanie Kingsland, Cassandra Lane, Maji Hailemariam, Rachel Sutherland, Nicole Nathan
BACKGROUND: The primary purpose of this review is to synthesise the effect of strategies aiming to sustain the implementation of evidenced-based interventions (EBIs) targeting key health behaviours associated with chronic disease (i.e. physical inactivity, poor diet, harmful alcohol use, and tobacco smoking) in clinical and community settings. The field of implementation science is bereft of an evidence base of effective sustainment strategies, and as such, this review will provide important evidence to advance the field of sustainability research...
May 9, 2024: Systematic Reviews
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
